Publication | Closed Access
PPARγ Agonist Pioglitazone Reverses Memory Impairment and Biochemical Changes in a Mouse Model of Type 2 Diabetes Mellitus
95
Citations
26
References
2012
Year
It is concluded that PPARγ agonist pioglitazone may be considered as potential pharmacological agents for the management of cognitive dysfunction in T2DM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1